Physician profile
Alyssa K Greenleaf
NPI 1861896524
$25,853.25
in general payments reported to CMS, 2019-2025
24 companies · $9,502 in 2025
The $9,502 reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $587 · 2023: $6,119 · 2024: $9,645 · 2025: $9,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $4,297 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,129.25 |
| Food and Beverage | $4,297.10 |
| Travel and Lodging | $839.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $22,352.40 | 2022-2025 | Cequr Simplicity |
| Dexcom, INC. | $663.90 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Abbott Laboratories | $564.11 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $428.59 | 2022-2025 | Ozempic |
| Amgen INC. | $387.80 | 2023-2025 | Tepezza, Prolia, Evenity |
| Medtronic, INC. | $240.24 | 2023-2025 | Minimed 780g, Intellis Adaptivestim |
| Tandem Diabetes Care, INC. | $225.46 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $176.05 | 2023-2024 | |
| Lilly USA, LLC | $155.05 | 2022-2023 | Jardiance, Baqsimi, Lyumjev |
| Insulet Corporation | $117.18 | 2023-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $111.01 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $61.01 | 2023-2024 | Strensiq |
| Corcept Therapeutics | $59.54 | 2024-2025 | Korlym |
| Mannkind Corporation | $44.14 | 2025 | |
| Sequel Med Tech, LLC | $41.60 | 2025 | Twiist |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $35.57 | 2025 | |
| Embecta Corp. | $28.64 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Sanofi-Aventis U.S. LLC | $28.02 | 2023 | |
| Abbvie INC. | $24.49 | 2023 | |
| Halozyme INC | $24.38 | 2023 | |
| Neurocrine Biosciences, INC. | $24.12 | 2025 | |
| Beta Bionics, INC. | $22.34 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Almatica Pharma LLC | $21.77 | 2025 | Teriparatide |
| Recordati_rare_diseases_inc. | $15.84 | 2023 | Signifor Lar, Isturisa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Greenleaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.